Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

46 results about "Bacterial Disorder" patented technology

Method for preparing chelerythrine medicament and application thereof in prevention and treatment of bacterial diseases of aquatic animals

The invention discloses a method for preparing a chelerythrine medicament and application thereof in prevention and treatment of bacterial diseases of aquatic animals. The medicament consists of chelerythrine and starch serving as an auxiliary material. The method for preparing the prevention and treatment agent comprises the following steps of: weighing chelerythrine extract (the purity is 80 percent) and starch serving as the auxiliary material, adding the chelerythrine extract and the starch into a mixer, and mixing the chelerythrine extract and the starch uniformly to obtain a preparation containing 5 to 20 percent chelerythrine. When the bacterial disease prevention and treatment agent is added into feed for feeding, the dosage is 200 to 250 mg/kg (according to the quantity of the chelerythrine for each kilogram of weight); the prevention and treatment agent added in the feed has low toxicity, does not affect the quality of aquatic products, has no residue or pollution, is not easy to generate medicament resistance, does not affect the feed and growth of the aquatic animals, has low dosage, and is widely applied in prevention and treatment of bacterial hemorrhage diseases of mandarin fish, weever, carp, grass carp, eel, porgy, flounder and the like.
Owner:PEARL RIVER FISHERY RES INST CHINESE ACAD OF FISHERY SCI

Compound microcapsule for treating bacterial disease of livestock and poultry and preparation method thereof

The invention discloses a compound microcapsule for treating bacterial disease of livestock and poultry and a preparation method thereof. The compound microcapsule mainly comprises the following components in part by weight: 10 to 20 parts of origano oil, 15 to 30 parts of levofloxacin and 30 to 60 parts of capsule material. The Chinese medicinal preparation origano oil is combined with the western medicine levofloxacin to prepare the compound microcapsule. The western medicine levofloxacin fast sterilizes, and the Chinese medicinal preparation origano oil assists sterilizing, and the origano oil and the levofloxacin can regulate body functions of the livestock and poultry and improves immunity at the same time. The compound microcapsule has the advantages of synergistic effects because of the combination of the Chinese medicinal preparation and the western medicine, obvious sterilizing effect, no toxic or side effect of the medicaments, and capability of treating both principal and secondary aspects of diseases. In addition, the compound microcapsule solves the problem of poor stability of the origano oil used as essential oil, and makes the origano oil easily and stably combined with the western medicine levofloxacin.
Owner:河南后羿制药有限公司

Methods of Chemical Synthesis and Purification of Diaminophenothiazinium Compounds Including Methylthioninium Chloride (Mtc)

This invention pertains generally to the field of chemical synthesis and purification, and more specifically to methods of synthesizing and purifying certain 3,7 diamino-phenothiazin-5-ium compounds (referred to herein as “diaminophenothiazinium compounds”) including Methylthioninium Chloride (MTC) (also known as Methylene Blue). In one embodiment, the method comprises the steps of, in order: nitrosylation (NOS); nitrosyl reduction (NR); thiosulfonic acid formation (TSAF); oxidative coupling (OC); Cr(VI) reduction (CR); isolation and purification of zwitterionic intermediate (IAPOZI); ring closure (RC); chloride salt formation (CSF); one of: sulphide treatment (ST); dimethyldithiocarbamate treatment (DT); carbonate treatment (CT); ethylenediaminetetraacetic acid treatment (EDTAT); organic extraction (OE); and recrystallisation (RX). The present invention also pertains to the resulting (high purity) compounds, compositions comprising them (e.g., tablets, capsules), and their use in methods of inactivating pathogens, and methods of medical treatment and diagnosis, etc., for example, for tauopathies, Alzheimer's disease (AD), skin cancer, melanoma, viral diseases, bacterial diseases, or protozoal diseases. Wherein: each of R1 and R9 is independently selected from: —H; C1-4 alkenyl; and halogenated C1-4alkyl; each of R3NA and R3NB is independently selected from: C1-4 alkyl; C2-4alkenyl; and halogenated C4-1 alkyl; each of R7NA and R7NB is independently selected from: C1-4 alkyl; C2-4alkenyl; and halogenated C1-4 alkyl; and X is one or more anionic counter ions to achieve electrical neutrality.
Owner:WISTA LAB LTD

Compound Chinese herbal medicine for inhibiting and killing aeromonas hydrophila as well as preparation method and application of compound Chinese herbal medicine

The invention discloses a compound Chinese herbal medicine for inhibiting and killing aeromonas hydrophila as well as a preparation method and application of the compound Chinese herbal medicine. The compound Chinese herbal medicine consists of gallnut, sanguisorba officinalis root and rheum officinale, wherein the weight ratio of the gallnut, to the sanguisorba officinalis root to the rheum officinale is at 5 to 2 to 1. Meanwhile, the invention discloses a preparation method and application of the compound Chinese herbal medicine for inhibiting and killing aeromonas hydrophila. The compound Chinese herbal medicine disclosed by the invention achieves the reasonable development and utilization of compound Chinese herbal medicine resources; in culture of aquatic animals, the compound Chinese herbal medicine has a great significance in guaranteeing animal nutrition, promoting growth of the animals and improving the disease preventing and disease resisting capacities of the animals, and meanwhile the compound Chinese herbal medicine is also in line with the requirements of aquaculture in sustainable development; in order to reduce loss of the aquaculture industry caused by diseases, a medicine, which is relatively strong in effect and low in toxic and side effects, becomes particularly important in the prevention and control of the diseases; and by taking the aeromonas hydrophila as a research object, the compound Chinese herbal medicine, which is relatively good in antibacterial effect, is screened out, so that the invention provides reference for prevention and control practice of diseases in aquatic animals and fish bacterial diseases caused by the aeromonas hydrophila.
Owner:SOUTHWEST UNIVERSITY

Feed formula for breeding poultry and broiler chickens

The invention belongs to the technical field of poultry breeding feed, and particularly relates to a feed formula for poultry broiler breeding, which comprises feed components and Chinese herbal medicine auxiliary material components, the feed component consists of the following raw materials in parts by weight: 38-55 parts of corn, 20-22 parts of soybean meal, 6-8 parts of peanut cakes, 3-5 parts of bran, 3-5 parts of fish meal, 9-12 parts of limestone flour, 1-3 parts of calcium hydrogen phosphate, 0.2-0.5 part of zinc sulfate, 0.1-0.5 part of methionine, 0.1-0.5 part of lysine, 0.1-0.5 part of vitamins for chickens, 0.5-2 parts of vegetable oil and 2-3 parts of an additive. According to the invention, mineral elements necessary for livestock and poultry are supplemented, so that the broiler chicken achieves relatively good nutrient balance, the weight gain of the broiler chicken is increased, and the chicken flavor is improved; the Chinese herbal medicine auxiliary material components are used for replacing antibiotics, so that chicken bacterial diseases, chicken paratyphoid fever and other chicken diseases can be prevented and treated, poultry broilers have excellent disease resistance and high survival rate, and meanwhile, the weight gain of the broilers is further improved.
Owner:霍邱县牧鹰农牧有限公司

Process for optimally extracting quercetin from perfoliote knotweed herb by using Plackett-Burnman combined response surface method

The invention discloses a process for optimally extracting quercetin from perfoliote knotweed herb by using a Plackett-Burnman combined response surface method. According to the process, the extraction amount of quercetin in perfoliote knotweed herb is taken as an investigation index, and extraction research is performed by adopting the Plackett-Burnman combined response surface method, so the optimal extraction process for quercetin in perfoliote knotweed herb is obtained; i.e., the perfoliote knotweed herb is soaked in ethanol with a concentration of 59.92% and accounting for 25 times of thevolume of the perfoliote knotweed herb for 24 hours, and then reflux extraction is conducted for 3.4 hours twice; under the condition of the extraction process, the average extraction amount of quercetin is 0.34 mg/g. An extract prepared by optimizing the extraction process is high in antibacterial activity, the MIC of the extract to escherichia coli, staphylococcus aureus and salmonella is 3.12g/L, 6.24 g/L and 6.31 g/L respectively, and the MBC of the extract to escherichia coli, staphylococcus aureus and salmonella is 12.52 g/L, 24.08 g/L and 25.41 g/L respectively; and the quercetin canbe used for treating livestock and poultry bacterial diseases caused by escherichia coli, staphylococcus aureus and salmonella.
Owner:GUIZHOU INST OF ANIMAL HUSBANDRY & VETERINARY

Application of total glycosides of Cistanche deserticola and echinacoside in the preparation of drugs for preventing and treating alcoholic liver injury with intestinal injury

The invention provides the application of total glycosides of cistanche deserticola and echinacoside in the preparation of medicines for preventing and treating alcoholic liver injury accompanied by intestinal injury and regulating intestinal flora. The results of pharmacological experiments showed that in the mouse model of alcoholic liver injury, total glycosides of cistanche and echinacoside could reduce the damage of liver tissue morphology in mice, reduce the lipid deposition in the liver of mice, and reduce the alanine aminotransferase (ALT) in mouse liver. ) and aspartate aminotransferase (AST) content, reduce the oxidative damage of mouse liver, reduce the damage of harmful substances such as endotoxin to the liver, and at the same time, it can also reduce the damage of mouse small intestine tissue morphology, improve the integrity of intestinal wall villi, and regulate intestinal The flora is disturbed. It can be seen that the present invention has the prospect of being developed into a drug capable of simultaneously protecting alcoholic liver injury and alcoholic intestinal injury, and has important clinical significance and commercial value.
Owner:PEKING UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products